Ming-Shyue Lee, Ph.D. - Publications

Affiliations: 
2002 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Molecular Biology, Biochemistry, Oncology

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Huang HP, Chen CH, Chang KH, Lee MS, Lee CF, Chao YH, Lu SY, Wu TF, Liang ST, Lin CY, Lin YC, Liu SP, Lu YC, Shun CT, Huang WJ, et al. Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study. Journal of Translational Medicine. 21: 714. PMID 37821919 DOI: 10.1186/s12967-023-04424-9  0.362
2023 Cho CC, Lin CJ, Huang HH, Yang WZ, Fei CY, Lin HY, Lee MS, Yuan HS. Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth. Acs Chemical Biology. PMID 37188336 DOI: 10.1021/acschembio.3c00065  0.436
2022 Lin HY, Ko CJ, Lo TY, Wu SR, Lan SW, Huang CA, Lin YC, Lin HH, Tu HF, Lee CF, Hsiao PW, Huang HP, Chen MJ, Chang KH, Lee MS. Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis. Oncogene. PMID 35418692 DOI: 10.1038/s41388-022-02303-z  0.419
2022 Lee CF, Chen YA, Hernandez E, Pong RC, Ma S, Hofstad M, Kapur P, Zhau H, Chung LW, Lai CH, Lin H, Lee MS, Raj GV, Hsieh JT. The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC. Clinical and Translational Medicine. 12: e695. PMID 35184376 DOI: 10.1002/ctm2.695  0.45
2020 Ko CJ, Hsu TW, Wu SR, Lan SW, Hsiao TF, Lin HY, Lin HH, Tu HF, Lee CF, Huang CC, Chen MM, Hsiao PW, Huang HP, Lee MS. Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis. Oncogene. PMID 32778768 DOI: 10.1038/S41388-020-01413-W  0.612
2020 Wu SR, Teng CH, Tu YT, Ko CJ, Cheng TS, Lan SW, Lin HY, Lin HH, Tu HF, Hsiao PW, Huang HP, Chen CH, Lee MS. Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells. Scientific Reports. 10: 2874. PMID 32051516 DOI: 10.1038/S41598-020-60001-W  0.55
2019 Lee CF, Dang A, Hernandez E, Pong RC, Chen B, Sonavane R, Raj G, Kapur P, Lin HY, Wu SR, Ko CJ, Lo UG, Lee HY, Hsieh JT, Lee MS. Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase. Oncogene. PMID 31152147 DOI: 10.1038/S41388-019-0833-3  0.5
2019 Wu SR, Lin CH, Shih HP, Ko CJ, Lin HY, Lan SW, Lin HH, Tu HF, Ho CC, Huang HP, Lee MS. HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis. British Journal of Cancer. PMID 30765871 DOI: 10.1038/S41416-019-0400-2  0.413
2018 Yu CH, Chou CC, Tu HF, Huang WC, Ho YY, Khoo KH, Lee MS, Chang GD. Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase. Oncotarget. 9: 21512-21529. PMID 29765556 DOI: 10.18632/Oncotarget.25177  0.362
2017 Wu SR, Teng CH, Tu YT, Ko CJ, Cheng TS, Lan SW, Lin HY, Lin HH, Tu HF, Hsiao PW, Huang HP, Chen CH, Lee MS. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells. Scientific Reports. 7: 15101. PMID 29118397 DOI: 10.1038/S41598-017-15415-4  0.616
2017 Lo UG, Lee CF, Lee MS, Hsieh JT. The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression. International Journal of Molecular Sciences. 18. PMID 28973968 DOI: 10.3390/Ijms18102079  0.525
2016 Su HC, Liang YA, Lai YJ, Chiu YL, Barndt RB, Shiao F, Chang HD, Lu DD, Huang N, Tseng CC, Wang JK, Lee MS, Johnson MD, Huang SM, Lin CY. Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner. Plos One. 11: e0167894. PMID 27936035 DOI: 10.1371/Journal.Pone.0167894  0.395
2016 Yang L, Lee MM, Leung MM, Wong YH. Regulator of G protein signaling 20 enhances cancer cell aggregation, migration, invasion and adhesion. Cellular Signalling. PMID 27495875 DOI: 10.1016/J.Cellsig.2016.07.017  0.349
2016 Ko C, Lu Y, Lai P, Hsiao P, Lee M. Abstract B67: Matriptase is involved in COX-2 signaling-induced prostate cancer cell invasion Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-B67  0.616
2015 Shyu HY, Ko CJ, Luo YC, Lin HY, Wu SR, Lan SW, Cheng TS, Hu SH, Lee MS. Ketamine Increases Permeability and Alters Epithelial Phenotype of Renal Distal Tubular Cells via a GSK-3β-Dependent Mechanism. Journal of Cellular Biochemistry. PMID 26365534 DOI: 10.1002/Jcb.25372  0.364
2015 Lai YJ, Chang HD, Lai H, Xu Y, Shiao F, Huang N, Li L, Lee MS, Johnson MD, Wang JK, Lin CY. N-Glycan Branching Affects the Subcellular Distribution of and Inhibition of Matriptase by HAI-2/Placental Bikunin. Plos One. 10: e0132163. PMID 26171609 DOI: 10.1371/Journal.Pone.0132163  0.367
2015 Ko CJ, Huang CC, Lin HY, Juan CP, Lan SW, Shyu HY, Wu SR, Hsiao PW, Huang HP, Shun CT, Lee MS. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis. Cancer Research. 75: 2949-60. PMID 26018085 DOI: 10.1158/0008-5472.Can-14-3297  0.599
2015 Tzeng S, Tsai C, Lee M, Hsiao P. Abstract B85: High malignant prostate cancer cells developed enhanced tumor-initiating/metastatasis-initiating activity and altered the lung microenvironment Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B85  0.525
2014 Tsai CH, Teng CH, Tu YT, Cheng TS, Wu SR, Ko CJ, Shyu HY, Lan SW, Huang HP, Tzeng SF, Johnson MD, Lin CY, Hsiao PW, Lee MS. HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase. Oncogene. 33: 4643-52. PMID 24121274 DOI: 10.1038/Onc.2013.412  0.56
2014 Hsu S, Hsiao Y, Yu S, Lee M. Abstract 1564: Spanxa1 is a novel mediator of epithelial-mesenchymal transition in lung cancer Cancer Research. 74: 1564-1564. DOI: 10.1158/1538-7445.Am2014-1564  0.451
2013 Lin CC, Lin CE, Lin YC, Ju TK, Huang YL, Lee MS, Chen JH, Lee H. Lysophosphatidic acid induces reactive oxygen species generation by activating protein kinase C in PC-3 human prostate cancer cells. Biochemical and Biophysical Research Communications. 440: 564-9. PMID 24113377 DOI: 10.1016/J.Bbrc.2013.09.104  0.546
2013 Cheng TS, Chen WC, Lin YY, Tsai CH, Liao CI, Shyu HY, Ko CJ, Tzeng SF, Huang CY, Yang PC, Hsiao PW, Lee MS. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis. Cancer Prevention Research (Philadelphia, Pa.). 6: 495-505. PMID 23466486 DOI: 10.1158/1940-6207.Capr-12-0293-T  0.607
2012 Deng YT, Chang TW, Lee MS, Lin JK. Suppression of free fatty acid-induced insulin resistance by phytopolyphenols in C2C12 mouse skeletal muscle cells. Journal of Agricultural and Food Chemistry. 60: 1059-66. PMID 22191431 DOI: 10.1021/Jf204496F  0.303
2012 Huang HP, Chang MH, Chen YT, Hsu HY, Chiang CL, Cheng TS, Wu YM, Wu MZ, Hsu YC, Shen CC, Lee CN, Chuang YH, Hong CL, Jeng YM, Chen PH, ... ... Lee MS, et al. Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation. Hepatology (Baltimore, Md.). 55: 161-72. PMID 21898507 DOI: 10.1002/Hep.24657  0.36
2012 Cheng T, Chen W, Lin Y, Liao C, Ko C, Lee M. Abstract 2000: Curcumin prevents human prostate cancer cell invasion by inhibiting of matriptase activity Cancer Research. 72: 2000-2000. DOI: 10.1158/1538-7445.Am2012-2000  0.602
2011 Chou FP, Xu H, Lee MS, Chen YW, Richards OX, Swanson R, Olson ST, Johnson MD, Lin CY. Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells. American Journal of Physiology. Cell Physiology. 301: C1093-103. PMID 21795523 DOI: 10.1152/Ajpcell.00122.2011  0.516
2011 Lan S, Cheng T, Wu S, Shyu H, Ko C, Hsiao P, Lee M. Abstract A54: Downregulation of hepatocyte growth factor activator inhibitor-2 is involved in the progression of prostate cancer cells Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-A54  0.591
2011 Wu S, Teng C, Tsai C, Tu Y, Cheng T, Shyu H, Ko C, Lan S, Huang H, Lin C, Hsiao P, Lee M. Abstract 1413: Hepatocyte growth factor activator inhibitor-2 inhibits prostate cancer cell migration and invasion Cancer Research. 71: 1413-1413. DOI: 10.1158/1538-7445.Am2011-1413  0.632
2010 Wu SR, Cheng TS, Chen WC, Shyu HY, Ko CJ, Huang HP, Teng CH, Lin CH, Johnson MD, Lin CY, Lee MS. Matriptase is involved in ErbB-2-induced prostate cancer cell invasion. The American Journal of Pathology. 177: 3145-58. PMID 20971737 DOI: 10.2353/Ajpath.2010.100228  0.599
2010 Chen YW, Lee MS, Lucht A, Chou FP, Huang W, Havighurst TC, Kim K, Wang JK, Antalis TM, Johnson MD, Lin CY. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. The American Journal of Pathology. 176: 2986-96. PMID 20382709 DOI: 10.2353/Ajpath.2010.090665  0.612
2009 Wang JK, Lee MS, Tseng IC, Chou FP, Chen YW, Fulton A, Lee HS, Chen CJ, Johnson MD, Lin CY. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. American Journal of Physiology. Cell Physiology. 297: C459-70. PMID 19535514 DOI: 10.1152/Ajpcell.00201.2009  0.456
2009 Veeramani S, Lee MS, Lin MF. Revisiting histidine-dependent acid phosphatases: a distinct group of tyrosine phosphatases. Trends in Biochemical Sciences. 34: 273-8. PMID 19467874 DOI: 10.1016/j.tibs.2009.03.002  0.472
2008 Tseng IC, Chou FP, Su SF, Oberst M, Madayiputhiya N, Lee MS, Wang JK, Sloane DE, Johnson M, Lin CY. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. American Journal of Physiology. Cell Physiology. 295: C423-31. PMID 18550704 DOI: 10.1152/Ajpcell.00164.2008  0.405
2007 Lee MS, Tseng IC, Wang Y, Kiyomiya K, Johnson MD, Dickson RB, Lin CY. Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. American Journal of Physiology. Cell Physiology. 293: C95-105. PMID 17344310 DOI: 10.1152/Ajpcell.00611.2006  0.411
2006 Kiyomiya K, Lee MS, Tseng IC, Zuo H, Barndt RJ, Johnson MD, Dickson RB, Lin CY. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells. American Journal of Physiology. Cell Physiology. 291: C40-9. PMID 16467405 DOI: 10.1152/Ajpcell.00351.2005  0.574
2005 Veeramani S, Igawa T, Yuan TC, Lin FF, Lee MS, Lin JS, Johansson SL, Lin MF. Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells. Oncogene. 24: 7203-12. PMID 16170380 DOI: 10.1038/sj.onc.1208852  0.716
2005 Oberst MD, Chen LY, Kiyomiya K, Williams CA, Lee MS, Johnson MD, Dickson RB, Lin CY. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. American Journal of Physiology. Cell Physiology. 289: C462-70. PMID 15800053 DOI: 10.1152/Ajpcell.00076.2005  0.467
2005 Lee MS, Kiyomiya K, Benaud C, Dickson RB, Lin CY. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. American Journal of Physiology. Cell Physiology. 288: C932-41. PMID 15590895 DOI: 10.1152/Ajpcell.00497.2004  0.38
2004 Lee MS, Igawa T, Lin MF. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells. Oncogene. 23: 3048-58. PMID 14990987 DOI: 10.1038/Sj.Onc.1207451  0.676
2004 Lee MS, Igawa T, Chen SJ, Van Bemmel D, Lin JS, Lin FF, Johansson SL, Christman JK, Lin MF. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas. International Journal of Cancer. 108: 672-8. PMID 14696093 DOI: 10.1002/Ijc.11621  0.741
2003 Zelivianski S, Spellman M, Kellerman M, Kakitelashvilli V, Zhou XW, Lugo E, Lee MS, Taylor R, Davis TL, Hauke R, Lin MF. ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. International Journal of Cancer. Journal International Du Cancer. 107: 478-85. PMID 14506750 DOI: 10.1002/ijc.11413  0.624
2003 Lee MS, Igawa T, Yuan TC, Zhang XQ, Lin FF, Lin MF. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells. Oncogene. 22: 781-96. PMID 12569372 DOI: 10.1038/Sj.Onc.1206066  0.752
2002 Igawa T, Lin FF, Lee MS, Karan D, Batra SK, Lin MF. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. The Prostate. 50: 222-35. PMID 11870800 DOI: 10.1002/Pros.10054  0.674
2001 Lin MF, Lee MS, Zhou XW, Andressen JC, Meng TC, Johansson SL, West WW, Taylor RJ, Anderson JR, Lin FF. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells. The Journal of Urology. 166: 1943-50. PMID 11586265  0.715
2001 Zhang XQ, Lee MS, Zelivianski S, Lin MF. Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells. The Journal of Biological Chemistry. 276: 2544-50. PMID 11067847 DOI: 10.1074/Jbc.M006661200  0.665
2000 Lin MF, Lee MS, Garcia-Arenas R, Lin FF. Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells. Cell Biology International. 24: 681-9. PMID 11023645 DOI: 10.1006/Cbir.2000.0433  0.681
2000 Meng TC, Lee MS, Lin MF. Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells. Oncogene. 19: 2664-77. PMID 10851066 DOI: 10.1038/Sj.Onc.1203576  0.723
Show low-probability matches.